Sentinel lymph node (SLN) biopsy for the treatment of ductal carcinoma in situ (DCIS) is not necessary and generally should be limited to those patients with a core needle biopsy diagnosis of DCIS who are undergoing mastectomy. Used in this way, SLN biopsy will spare the majority of patients with oc
โฆ LIBER โฆ
Predictors of invasion in patients with core-needle biopsy-diagnosed ductal carcinoma in situ and recommendations for a selective approach to sentinel lymph node biopsy in ductal carcinoma in situ
โ Scribed by Lei Huo; Nour Sneige; Kelly K. Hunt; Constance T. Albarracin; Adriana Lopez; Erika Resetkova
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 120 KB
- Volume
- 107
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Sentinel lymph node biopsy in patients w
โ
Kelly M. McMasters; Celia Chao; Sandra L. Wong; Robert C. G. Martin III; Michael
๐
Article
๐
2002
๐
John Wiley and Sons
๐
English
โ 63 KB
๐ 1 views
Risk of invasion and axillary lymph node
โ
P. Meijnen; H. S. A. Oldenburg; C. E. Loo; O. E. Nieweg; J. L. Peterse; E. J. T.
๐
Article
๐
2007
๐
John Wiley and Sons
๐
English
โ 105 KB
๐ 1 views
A concept for the clinical implementatio
โ
Thorsten Kuehn; Andreas Bembenek; Thomas Decker; Dieter Ludwig Munz; Marie-Luise
๐
Article
๐
2005
๐
John Wiley and Sons
๐
English
โ 111 KB
๐ 1 views
## Abstract The development of standardized and reproducible clinical pathways is an important precondition for quality assurance in medicine, especially if a new method has not yet been ultimately validated. Sentinel lymph node biopsy (SLNB) is a widely accepted new surgical procedure in the treat